Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome
Pathology & Oncology Research2007Vol. 13(3), pp. 243–247
Citations Over TimeTop 10% of 2007 papers
Anita Maász, Péter Kisfali, Katalin Horvatovich, Márion Mohás, Lajos Markó, Veronika Csöngei, Bernadett Faragó, Luca Járomi, Lili Magyari, Enikő Sáfrány, Csilla Sipeky, István Wittmann, Béla Melegh
Related Papers
- → Effect of Exogenous or Endogenous Gastric Inhibitory Polypeptide (GIP) on Plasma Triglyceride Responses in Rats(1991)81 cited
- → Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia(1988)109 cited
- → Effect of Exercise and Diet on Triglyceride Metabolism in Rats with Moderate Insulin Deficiency(1983)10 cited
- → Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model(1986)4 cited
- → Is the Glucocorticoid-Induced Hypertriglyceridemia in Uremic Rats Caused by Decreased Tissue Lipoprotein Lipase Activity?(1985)